Literature DB >> 25799162

The platform trial: an efficient strategy for evaluating multiple treatments.

Scott M Berry1, Jason T Connor2, Roger J Lewis3.   

Abstract

Mesh：

Year:  2015        PMID： 25799162     DOI： 10.1001/jama.2015.2316

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  81 in total

1.  The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.

Authors:  Munyaradzi Dimairo; Philip Pallmann; James Wason; Susan Todd; Thomas Jaki; Steven A Julious; Adrian P Mander; Christopher J Weir; Franz Koenig; Marc K Walton; Jon P Nicholl; Elizabeth Coates; Katie Biggs; Toshimitsu Hamasaki; Michael A Proschan; John A Scott; Yuki Ando; Daniel Hind; Douglas G Altman
Journal:  BMJ       Date:  2020-06-17

2.  Point-of-Care Clinical Trials in Sports Medicine Research: Identifying Effective Treatment Interventions Through Comparative Effectiveness Research.

Authors:  Kenneth C Lam; Cailee E Welch Bacon; Eric L Sauers; R Curtis Bay
Journal:  J Athl Train       Date:  2019-10-16       Impact factor: 2.860

3.  Paediatric cardiopulmonary bypass surgery: the challenges of heterogeneity and identifying a meaningful endpoint for clinical trials.

Authors:  V J Pappachan; K L Brown; S M Tibby
Journal:  Intensive Care Med       Date:  2016-11-18       Impact factor: 17.440

4.  Answering patient-centred questions efficiently: response-adaptive platform trials in primary care.

Authors:  Christopher C Butler; Jason T Connor; Roger J Lewis; Kristine Broglio; Benjamin R Saville; Johanna Cook; Alike van der Velden; Theo Verheij
Journal:  Br J Gen Pract       Date:  2018-06       Impact factor: 5.386

5.  Do trials that report a neutral or negative treatment effect improve the care of critically ill patients? Yes.

Authors:  Anders Perner; Simon Finfer
Journal:  Intensive Care Med       Date:  2018-06-11       Impact factor: 17.440

6.  Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis.

Authors:  Christopher W Seymour; Jason N Kennedy; Shu Wang; Chung-Chou H Chang; Corrine F Elliott; Zhongying Xu; Scott Berry; Gilles Clermont; Gregory Cooper; Hernando Gomez; David T Huang; John A Kellum; Qi Mi; Steven M Opal; Victor Talisa; Tom van der Poll; Shyam Visweswaran; Yoram Vodovotz; Jeremy C Weiss; Donald M Yealy; Sachin Yende; Derek C Angus
Journal:  JAMA       Date:  2019-05-28       Impact factor: 56.272

7.  ASPI: a public-private partnership to develop treatments for autism.

Authors:  Seth Ness; Gahan Pandina; Shyla Jagannatha; Kyle Wathen; Abigail Bangerter; Nikolay V Manyakov; Robert Hendren; Bennett Leventhal; Declan Murphy; Geraldine Dawson; Wayne C Drevets; Husseini K Manji
Journal:  Nat Rev Drug Discov       Date:  2020-04       Impact factor: 84.694

Review 8.  Adaptive trial designs for spinal cord injury clinical trials directed to the central nervous system.

Authors:  James D Guest; John D Steeves; M J Mulcahey; Linda A T Jones; Frank Rockhold; Rϋediger Rupp; John L K Kramer; Steven Kirshblum; Andrew Blight; Daniel Lammertse
Journal:  Spinal Cord       Date:  2020-09-16       Impact factor: 2.772

Review 9.  Adaptive Designs for Clinical Trials: Application to Healthcare Epidemiology Research.

Authors:  W Charles Huskins; Vance G Fowler; Scott Evans
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

Review 10.  Comorbidity in older adults with cancer.

Authors:  Grant R Williams; Amy Mackenzie; Allison Magnuson; Rebecca Olin; Andrew Chapman; Supriya Mohile; Heather Allore; Mark R Somerfield; Valerie Targia; Martine Extermann; Harvey Jay Cohen; Arti Hurria; Holly Holmes
Journal:  J Geriatr Oncol       Date:  2015-12-22       Impact factor: 3.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.